OXYBUTYNIN CHLORIDE tablet

Land: Verenigde Staten

Taal: Engels

Bron: NLM (National Library of Medicine)

Koop het nu

Download Productkenmerken (SPC)
25-12-2017

Werkstoffen:

OXYBUTYNIN CHLORIDE (UNII: L9F3D9RENQ) (OXYBUTYNIN - UNII:K9P6MC7092)

Beschikbaar vanaf:

St Marys Medical Park Pharmacy

INN (Algemene Internationale Benaming):

OXYBUTYNIN CHLORIDE

Samenstelling:

OXYBUTYNIN CHLORIDE 5 mg

Prescription-type:

PRESCRIPTION DRUG

Autorisatie-status:

Abbreviated New Drug Application

Productkenmerken

                                OXYBUTYNIN CHLORIDE - OXYBUTYNIN CHLORIDE TABLET
ST MARYS MEDICAL PARK PHARMACY
----------
OXYBUTYNIN CHLORIDE TABLETS USP
Rev. C 4/2012
DESCRIPTION
Oxybutynin chloride tablets USP are very pale blue, round, biconvex,
scored, debossed tablets
containing 5 mg of oxybutynin chloride, USP. Chemically, oxybutynin
chloride, USP is d,l (racemic) 4-
diethylamino-2-butynyl phenylcyclohexylglycolate hydrochloride. The
structural formula appears
below:
C
H NO •HCL M.W. 393.9
Oxybutynin chloride, USP is a white crystalline solid. It is readily
soluble in water and acids, but
relatively insoluble in alkalis.
Oxybutynin chloride tablets USP also contain calcium stearate,
microcrystalline cellulose, anhydrous
lactose, sodium starch glycolate and FD&C Blue #1 Aluminum Lake.
Oxybutynin chloride tablets USP are for oral administration.
Meets USP Dissolution Test 2.
Therapeutic Category: Antispasmodic, anticholinergic.
CLINICAL PHARMACOLOGY
Oxybutynin chloride exerts a direct antispasmodic effect on smooth
muscle and inhibits the muscarinic
action of acetylcholine on smooth muscle. Oxybutynin chloride exhibits
only one fifth of the
anticholinergic activity of atropine on the rabbit detrusor muscle,
but four to ten times the antispasmodic
activity. No blocking effects occur at skeletal neuromuscular
junctions or autonomic ganglia
(antinicotinic effects).
Oxybutynin chloride relaxes bladder smooth muscle. In patients with
conditions characterized by
involuntary bladder contractions, cystometric studies have
demonstrated that oxybutynin chloride
increases bladder (vesical) capacity, diminishes the frequency of
uninhibited contractions of the
detrusor muscle, and delays the initial desire to void. Oxybutynin
chloride thus decreases urgency and
the frequency of both incontinent episodes and voluntary urination.
Antimuscarinic activity resides predominately in the R-isomer. A
metabolite, desethyloxybutynin, has
pharmacological activity similar to that of oxybutynin in _invitro_
studies.
22
31
3
PHARMACOKINETICS
Absorption
Following or
                                
                                Lees het volledige document
                                
                            

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten